Safety and activity of ivosidenib in patients with IDH1-mutant advanced cholangiocarcinoma: a phase 1 study

Maeve A. Lowery, Howard A. Burris, F. Janku, Rachna T. Shroff, James M. Cleary, Nilofer S. Azad, Lipika Goyal, Elizabeth A. Maher, Lia Gore, Antoine Hollebecque, Muralidhar Beeram, Jonathan C. Trent, Liewen Jiang, Bin Fan, Elia Aguado-Fraile, Sung Choe, Bin Wu, Camelia Gliser, Samuel V. Agresta, Shuchi S. PandyaAndrew X. Zhu, Ghassan K. Abou-Alfa

Research output: Contribution to journalArticlepeer-review

103 Scopus citations

Fingerprint

Dive into the research topics of 'Safety and activity of ivosidenib in patients with IDH1-mutant advanced cholangiocarcinoma: a phase 1 study'. Together they form a unique fingerprint.

Medicine & Life Sciences